Unique ID issued by UMIN | UMIN000026425 |
---|---|
Receipt number | R000030359 |
Scientific Title | A prospective observational biomarker study for lung cancer immunotherapy |
Date of disclosure of the study information | 2017/03/06 |
Last modified on | 2022/09/09 12:12:05 |
A prospective observational biomarker study for lung cancer immunotherapy
Immuno-Oncology Biomarker Study (LC-SCRUM-IBIS)
A prospective observational biomarker study for lung cancer immunotherapy
Immuno-Oncology Biomarker Study (LC-SCRUM-IBIS)
Japan |
Lung cancer
Pneumology | Hematology and clinical oncology |
Malignancy
YES
This Study is intended to analyze the expression of PD-L1 and changes in various somatic genes associated with lung cancer, and by evaluating the relationship between the results of such analysis and clinicopathologic factors, therapeutic effects, and prognosis, and to explore new biomarkers for immune therapies for treatment of lung cancer.
Others
The incidence of expression of PD-L1 in lung cancer
Exploratory
Others
Not applicable
The incidence of expression of PD-L1 in lung cancer
Observational
Not applicable |
Not applicable |
Male and Female
1) Patients with a pathologic diagnosis of lung cancer (either biopsy or cytological diagnosis);
2) Patients who are or will be enrolled in one of the 3 observational studies of LC-SCRUM-Japan, and at the same time, in whom fresh frozen sample + 10 slides of unstained preparation for genetic analysis and blood samples can be collected; and
3) Patients who consent in writing to take part in the Study.
Not applicable
1000
1st name | |
Middle name | |
Last name | Koichi Goto |
National Cancer Center Hospital East
Department of Thoracic Oncology
6-5-1, Kashiwanoha, Kashiwa, Chiba, Japan
04-7133-1111
kgoto@east.ncc.go.jp
1st name | |
Middle name | |
Last name | Kiyotaka Yoh |
National Cancer Center Hospital East
Department of Thoracic Oncology
6-5-1, Kashiwanoha, Kashiwa, Chiba, Japan
04-7133-1111
kyoh@east.ncc.go.jp
National Cancer Center Hospital East
ONO PHARMACEUTICAL CO., LTD.
CHUGAI PHARMACEUTICAL CO., LTD.
AstraZeneca K.K.
Profit organization
NO
2017 | Year | 03 | Month | 06 | Day |
Unpublished
No longer recruiting
2017 | Year | 01 | Month | 25 | Day |
2017 | Year | 01 | Month | 24 | Day |
2017 | Year | 02 | Month | 14 | Day |
2023 | Year | 03 | Month | 31 | Day |
The incidence of expression of PD-L1 in lung cancer
2017 | Year | 03 | Month | 06 | Day |
2022 | Year | 09 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030359
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |